Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Xinjiang Tianye Co.,Ltd. (600075.SS)
Shihezi, CN
Xinjiang Tianye Co.,Ltd. is engaged in the fabrication and distribution of a wide array of products, primarily chemicals, serving both domestic Chinese and international markets. Its extensive product catalog features numerous items, such as polyvinyl chloride (PVC) resin, a variety of paste and specialized resins, alongside industrial chemicals including caustic soda, calcium carbide, granular alkali, hydrochloric acid, citric acid, and acetylene gas. Beyond these, the company also supplies clinkers, various plastic goods like drip tapes and woven bags, food products such as tomato pastes, and cement-based materials. This enterprise was established in 1996 and maintains its operational base in Shihezi, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.14% | -6.84% | -26.53% | -23.75% | +1.61% | +1.82% | +20.00% | +0.80% | -31.52% | -34.80% | +101.60% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-6.0% Q1'26: -0.5% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-175.0% Q1'26: -200.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-5.1% Q1'26: +3.9% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+2.5% Q1'26: +1.0% (vs Q1'25)
-
ROIC Chemicals: +3.4%+1.2% Q1'26: +0.7% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+11.2% Q1'26: +13.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×4.94× Q1'26: 65.91× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.60B
est: 6.41B (-12.6%)
|
6.13B
est.
|
4.83B
est: 6.46B (-25.3%)
|
4.24B
est: 6.46B (-34.3%)
|
8.47B
est: 4.95B (+71.1%)
|
9.34B
est: 9.04B (+3.2%)
|
12.01B
est: 10.08B (+19.2%)
|
14.26B
est: 12.20B (+16.9%)
|
11.47B
est: 12.44B (-7.8%)
|
11.16B
est: 13.72B (-18.7%)
|
10.49B
est: 13.86B (-24.3%)
|
| EBITDA |
1.10B
est: 885.12M (+24.3%)
|
847.67M
est.
|
990.24M
est: 892.72M (+10.9%)
|
1.15B
est: 892.72M (+29.1%)
|
1.57B
est: 683.85M (+129.4%)
|
1.80B
est: 1.25B (+44.4%)
|
2.65B
est: 1.39B (+90.1%)
|
2.10B
est: 1.69B (+24.7%)
|
262.51M
est: 1.72B (-84.7%)
|
1.24B
est: 1.69B (-26.4%)
|
1.18B
est: 1.70B (-30.8%)
|
| EBIT |
755.78M
est: 499.72M (+51.2%)
|
478.58M
est.
|
655.39M
est: 504.01M (+30.0%)
|
815.33M
est: 504.01M (+61.8%)
|
979.49M
est: 386.09M (+153.7%)
|
1.24B
est: 705.46M (+76.3%)
|
2.10B
est: 786.14M (+167.5%)
|
1.33B
est: 952.10M (+39.5%)
|
-511.13M
est: 970.58M (-152.7%)
|
419.39M
est: 783.63M (-46.5%)
|
256.43M
est: 791.59M (-67.6%)
|
| Net Income |
489.30M
est: 794.34M (-38.4%)
|
1.25B
est.
|
493.59M
est: 1.33B (-63.0%)
|
539.02M
est: 1.33B (-59.6%)
|
543.84M
est: 1.04B (-47.9%)
|
886.57M
est: 1.04B (-14.3%)
|
1.64B
est: 1.92B (-14.5%)
|
904.22M
est: 1.61B (-43.8%)
|
-775.40M
est: 1.80B (-143.2%)
|
68.43M
est: 2.30B (-97.0%)
|
-57.07M
est: 818.07M (-107.0%)
|
| SGA |
403.99M
est: 331.37M (+21.9%)
|
317.34M
est.
|
538.71M
est: 334.21M (+61.2%)
|
452.35M
est: 334.21M (+35.3%)
|
701.46M
est: 256.01M (+174.0%)
|
511.36M
est: 467.79M (+9.3%)
|
583.68M
est: 521.29M (+12.0%)
|
753.72M
est: 631.34M (+19.4%)
|
604.89M
est: 643.59M (-6.0%)
|
554.58M
est: 605.93M (-8.5%)
|
177.66M
est: 612.08M (-71.0%)
|
| EPS |
0.59
est: 0.46 (+27.1%)
|
0.73
est.
|
0.51
est: 0.78 (-34.6%)
|
0.61
est: 0.78 (-21.8%)
|
0.44
est: 0.61 (-27.9%)
|
0.66
est: 0.61 (+9.1%)
|
1.07
est: 1.12 (-4.5%)
|
0.53
est: 0.94 (-43.6%)
|
-0.45
est: 1.05 (-142.9%)
|
0.04
est: 1.21 (-96.7%)
|
-0.03
est: 0.43 (-107.0%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-25 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Qiang Zhang | Chairman of the Board | 974.9K | male |
| Jianliang Chen | Financial Director & Chief Financial Officer | 438.5K | male |
| Suo Wang | Quality Supervisor | 422.9K | female |
| Shenglong Li | Secretary of the Board of Directors | 396.1K | male |
| Xinyang Xiong | Deputy General Manager | 385.9K | male |
| Jianlin Li | GM & Director | 239.0K | male |
| Li Feng | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 600075.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
